Efficacy of MiraNet Combi, a novel alpha-cypermethrin, pyriproxyfen, and piperonyl butoxide long-lasting insecticidal net against pyrethroid-resistant Anopheles funestus in western Kenya
PLOS One · 2026
DOI: 10.1371/journal.pone.0331995 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Mathew Kipsum und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Global Health, Kenya Medical Research Institute, Kisumu, Kenya. Hauptthemen laut MEDLINE: Anopheles, Pyrethrins, Piperonyl Butoxide, Insecticide-Treated Bednets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The widespread use of pyrethroid-only long-lasting insecticidal nets (LLINs) has contributed substantially to malaria control; however, increasing pyrethroid resistance in malaria vectors threatens their continued effectiveness. To address this challenge, LLINs incorporating additional active ingredients have been developed. MiraNet® Combi is a novel LLIN incorporating alpha-cypermethrin, the insect growth regulator pyriproxyfen (PPF), and the synergist piperonyl butoxide (PBO).
Methods
We evaluated the efficacy of MiraNet® Combi against pyrethroid-resistant Anopheles funestus in western Kenya using WHO cone bioassays, tunnel tests, experimental hut trials, and chemical analysis. Non-inferiority of MiraNet® Combi to Royal Guard® (alpha-cypermethrin + PPF) and superiority to Olyset® Plus (permethrin + PBO) and MiraNet® (alpha-cypermethrin-only) were assessed for mosquito mortality and blood-feeding inhibition following 20 standardized washes, in accordance with WHO guidelines.
Results
In laboratory assays, MiraNet® Combi achieved high efficacy, inducing 94.5% mortality (95% CI: 91.2–97.8%) and 93.8% blood-feeding inhibition (95% CI: 90.5–97.1%) across all wash points against susceptible and resistant mosquito strains. In experimental hut trials, MiraNet® Combi produced the highest mortality, with 23% (95% CI: 21–25%) in unwashed and 25% (95% CI: 23–27%) in washed nets, significantly exceeding unwashed Olyset® Plus (19.9%, p = 0.0002) and MiraNet® (21.9%, p = 0.03). Blood-feeding inhibition was comparable across all ITNs (90.2–98.4%). Unwashed MiraNet® Combi reduced ovary development by 37.5% (95% CI: 32.1–42.9%), decreasing to 14.3% (95% CI: 10.2–18.4%) after washing. MiraNet® Combi was non-inferior to Royal Guard® for mosquito mortality but not for blood-feeding inhibition, superior to Olyset® Plus and MiraNet® for mosquito mortality, superior to MiraNet® for blood-feeding inhibition, and inferior to Olyset® Plus for blood-feeding inhibition.
Conclusions
MiraNet® Combi provides improved personal protection and enhanced efficacy against pyrethroid-resistant An. funestus compared with existing LLINs. The combination of a pyrethroid, PBO, and PPF represents a promising strategy for resistance management and malaria vector control in areas with high pyrethroid resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Global Health, Kenya Medical Research Institute, Kisumu, Kenya.
- Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno, Kenya.
- Research World Limited Company, Kisumu, Kenya.
- Vector Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
- Centre for Infectious and Parasitic Disease Control Research, Kenya Medical Research Institute, Busia, Kenya.
ORCID-Profile: Mathew Kipsum, Collins Ouma, Eric Ochomo
Zitieren
APA
Kipsum, M., Agumba, S., Moshi, V., Muchoki, M., Omondi, S., Wekesa, C., Ouma, C., Abong'o, B., & Ochomo, E. (2026). Efficacy of MiraNet Combi, a novel alpha-cypermethrin, pyriproxyfen, and piperonyl butoxide long-lasting insecticidal net against pyrethroid-resistant Anopheles funestus in western Kenya. PLOS One. https://doi.org/10.1371/journal.pone.0331995
Vancouver
Kipsum M, Agumba S, Moshi V, Muchoki M, Omondi S, Wekesa C, et al. Efficacy of MiraNet Combi, a novel alpha-cypermethrin, pyriproxyfen, and piperonyl butoxide long-lasting insecticidal net against pyrethroid-resistant Anopheles funestus in western Kenya. PLOS One. 2026. doi:10.1371/journal.pone.0331995
BibTeX
@article{Kipsum2026,
author = {Kipsum, Mathew and Agumba, Silas and Moshi, Vincent and Muchoki, Margaret and Omondi, Seline and Wekesa, Celestine and Ouma, Collins and Abong'o, Bernard and Ochomo, Eric},
title = {Efficacy of MiraNet Combi, a novel alpha-cypermethrin, pyriproxyfen, and piperonyl butoxide long-lasting insecticidal net against pyrethroid-resistant Anopheles funestus in western Kenya},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0331995}
}
EUVIMED